Greinix H T, Faé I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B, Kalhs P, Lechner K, Mayr W R, Fischer G F
Department of Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Bone Marrow Transplant. 2005 Jan;35(1):57-62. doi: 10.1038/sj.bmt.1704741.
There is consensus that matching of unrelated donors (URD) and patients for HLA class II alleles improves the outcome of hematopoietic stem cell transplantation (HSCT). However, the significance of HLA class I allelic mismatches for transplant outcome is under discussion and reports on long-term effects like chronic graft-versus-host disease (GVHD) are rare. Thus, we investigated the association of human leukocyte antigen (HLA) class I allele mismatches and outcome in 144 patients given HSCT from URD who were matched for HLA-DRB1, DRB3/4/5, and DQB1 alleles. The risk of chronic GVHD was significantly increased in patients with class I mismatched donors, the mismatch either detected by low- or high-resolution typing. A single HLA class I allele mismatch significantly increased the risk of chronic GVHD in multivariate analysis. Overall survival was significantly reduced in patient/donor pairs with more than one-allele class I mismatch. Thus, selection of unrelated donors for transplantation should be based on high-resolution HLA class I typing.
目前已达成共识,非亲缘供者(URD)与患者的人类白细胞抗原(HLA)II类等位基因匹配可改善造血干细胞移植(HSCT)的预后。然而,HLA I类等位基因错配对于移植预后的意义仍在讨论中,关于慢性移植物抗宿主病(GVHD)等长期影响的报道很少。因此,我们研究了144例接受URD的HSCT患者中人类白细胞抗原(HLA)I类等位基因错配与预后的关系,这些患者的HLA-DRB1、DRB3/4/5和DQB1等位基因相匹配。I类错配供者的患者发生慢性GVHD的风险显著增加,错配通过低分辨率或高分辨率分型检测到。在多变量分析中,单个HLA I类等位基因错配显著增加了慢性GVHD的风险。在具有一个以上I类等位基因错配的患者/供者对中,总生存率显著降低。因此,移植非亲缘供者的选择应基于HLA I类高分辨率分型。